Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 361 AL 375

[Violence against disabled persons]

Schulte-Wissermann H.

Kinderkrankenschwester. 2014 Jun;33(6):208.

Effectiveness and cost-effectiveness of the pharmacological treatment of Alzheimer's disease and vascular dementia

Versijpt J.

J Alzheimers Dis. 2014;42 Suppl 3:S19-25. doi: 10.3233/JAD-132639.

Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases

Hyttinen JM, Amadio M, Viiri J, Pascale A, Salminen A, Kaarniranta K.

Ageing Res Rev. 2014 Nov;18:16-28. doi: 10.1016/j.arr.2014.07.002. Epub 2014 Jul 22.

Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways

Regitz C, Dußling LM, Wenzel U.

Mol Nutr Food Res. 2014 Oct;58(10):1931-40. doi: 10.1002/mnfr.201400014. Epub 2014 Jul 28.

[Role of apolipoprotein E in the molecular pathomechanism of Alzheimer disease]

Michikawa M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2014 Feb;34(1):5-9.

Functional connectivity in autosomal dominant and late-onset Alzheimer disease

Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, Ourselin S, Schofield PR, Masters CL, Martins RN, Weiner MW, Thompson PM, Fox NC, Koeppe RA, Jack CR Jr, Mathis CA, Oliver A, Blazey TM, Moulder K, Buckles V, Hornbeck R, Chhatwal J, Schultz AP, Goate AM, Fagan AM, Cairns NJ, Marcus DS, Morris JC, Ances BM.

JAMA Neurol. 2014 Sep;71(9):1111-22. doi: 10.1001/jamaneurol.2014.1654.

Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease

Blair LJ, Sabbagh JJ, Dickey CA.

Expert Opin Ther Targets. 2014 Oct;18(10):1219-32. doi: 10.1517/14728222.2014.943185. Epub 2014 Jul 29.

Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme

Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, Deary IJ, Elliott J, Gunnell D, Harris SE, Kivimaki M, Kumari M, Martin RM, Power C, Sayer AA, Starr JM, Kuh D, Day IN; HALCyon Study Team.

Age (Dordr). 2014;36(4):9673. doi: 10.1007/s11357-014-9673-9. Epub 2014 Jul 30.

[The involvement of hippocampal cholinergic neurostimulating peptide and its precursor in Alzheimer pathogenesis]

Matsukawa N.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2014 Jun;34(3):93-100.

When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease

Avila-Muñoz E, Arias C.

Ageing Res Rev. 2014 Nov;18:29-40. doi: 10.1016/j.arr.2014.07.004. Epub 2014 Jul 28.

Preclinical Alzheimer's disease therapeutics

Rafii MS.

J Alzheimers Dis. 2014;42 Suppl 4:S545-9. doi: 10.3233/JAD-141482.

Targeting thrombin: an inflammatory neurotoxin in Alzheimer's disease

Grammas P, Martinez JM.

J Alzheimers Dis. 2014;42 Suppl 4:S537-44. doi: 10.3233/JAD-141557.

Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease

Panza F, Solfrizzi V, Imbimbo BP, Giannini M, Santamato A, Seripa D, Logroscino G.

Expert Rev Neurother. 2014 Sep;14(9):973-86. doi: 10.1586/14737175.2014.945522. Epub 2014 Aug 1.

Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage

Wang F, Guo X, Shen X, Kream RM, Mantione KJ, Stefano GB.

Med Sci Monit Basic Res. 2014 Aug 1;20:118-29. doi: 10.12659/MSMBR.891278.

Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum

Ríos JA, Cisternas P, Arrese M, Barja S, Inestrosa NC.

Prog Neurobiol. 2014 Oct;121:125-46. doi: 10.1016/j.pneurobio.2014.07.004. Epub 2014 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias